Diagnosis of Respiratory Viruses in Children With Rhinoswab Junior
SARS CoV 2 Infection, COVID-19
About this trial
This is an interventional diagnostic trial for SARS CoV 2 Infection focused on measuring Rhinoswab Junior
Eligibility Criteria
Inclusion Criteria:
- Symptomatic and requiring a COVID-19 test at RCH or confirmed/suspected COVID-19 at home.
- Aged between 1 month -18 years old.
- Parent/guardian present.
- Parents/self are able to provide consent.
Exclusion Criteria:
- < 1 month or >18 years old.
- Recent head or neck surgery
- Inability (e.g. non-English speaking and if no interpreter is available) or unwillingness to consent
Sites / Locations
- Shidan Tosif
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
Arm 1 - Clinician Collected/supervised Rhinoswab first, then CTDN swab
Arm 2 - Clinician Collected/supervised CTDN swab first, then Rhinoswab
Arm 3 - Self-collected Rhinoswab, saliva swab, CTDN
Arm 4 - Self-collected RAT, saliva, CTDN
Rhinoswab test administered and immediately followed by CTDN. Rhinoswab swab tested on respiratory panel vs CTDN swab tested on respiratory panel (standard of care).
CTDN test administered and immediately followed by Rhinoswab. CTDN swab tested on respiratory panel (standard of care) vs Rhinoswab swab tested on respiratory panel.
In children 5-18 years, the child/parent/guardian collects the three samples, in order of patient/parent preference. All samples will be tested on the SARS-CoV-2 laboratory panel (Allplex™ SARS-CoV-2 Assay - Seegene Inc)
In children 1 month -5 years, the child/parent/guardian collects the three samples, in order of patient/parent preference. Saliva and CTDN samples will be tested on the SARS-CoV-2 laboratory panel (Allplex™ SARS-CoV-2 Assay - Seegene Inc), RAT test kit will be Abbott PanBio